drugset / Trial / NCT00050076
Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine the effect of two different doses of MCC-135, once daily (QD) or twice daily (BID), on the disease state and the quality of life in subjects with congestive heart failure.
Timeline
- Start
- 2002-08
- Primary completion
- 2003-08
- Completion
- 2003-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CALDARET | Small molecule | 50 mg | Oral |
| Subject | CALDARET | Small molecule | 100 mg | Oral |
| Subject | CALDARET | Small molecule | 200 mg | Oral |